ALK and inflammatory myofibroblastic tumor: Around 50% of IMT cases harbor a clonal translocation that activates the anaplastic lymphoma kinase (ALK)-receptor tyrosine kinase gene located at 2p23 locus.[5] As a result, ALK protein is overexpressed and can be detected by immunohistochemical tests.